BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 18282435)

  • 1. [Managing children with neurofibromatosis type 1: what should we look for?].
    Martins CL; Monteiro JP; Farias A; Fernandes R; Fonseca MJ
    Acta Med Port; 2007; 20(5):393-400. PubMed ID: 18282435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurological complications involving the central nervous system in neurofibromatosis type 1.
    Hsieh HY; Wu T; Wang CJ; Chin SC; Chen YR
    Acta Neurol Taiwan; 2007 Jun; 16(2):68-73. PubMed ID: 17685129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neurofibromatosis type 1 (von Recklinghausen's disease or peripheral neurofibromatosis): from phenotype to gene].
    Sabol Z; Kipke-Sabol L
    Lijec Vjesn; 2005; 127(11-12):303-11. PubMed ID: 16583938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1.
    Hyman SL; Shores A; North KN
    Neurology; 2005 Oct; 65(7):1037-44. PubMed ID: 16217056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic delay of NF1 in hemifacial hypertrophy due to plexiform neurofibromas.
    Overdiek A; Feifel H; Schaper J; Mayatepek E; Rosenbaum T
    Brain Dev; 2006 Jun; 28(5):275-80. PubMed ID: 16481142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype.
    Pasmant E; Sabbagh A; Hanna N; Masliah-Planchon J; Jolly E; Goussard P; Ballerini P; Cartault F; Barbarot S; Landman-Parker J; Soufir N; Parfait B; Vidaud M; Wolkenstein P; Vidaud D; France RN
    J Med Genet; 2009 Jul; 46(7):425-30. PubMed ID: 19366998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neurofibromatosis in children. Our experience].
    López-Pisón J; Cuadrado-Martín M; Boldova-Aguar MC; Muñoz-Mellado A; Cabrerizo de Diago R; Peña-Segura JL
    Rev Neurol; 2003 Nov 1-15; 37(9):820-5. PubMed ID: 14606048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lisch nodules. Markers for a non-invasive diagnosis in Recklinghausen neurofibromatosis].
    Crişan M; Talu S; Florea M; Coprean D; Cosgarea R; Crişan D
    Oftalmologia; 2008; 52(4):56-61. PubMed ID: 19354164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproductive decisions after prenatal diagnosis in neurofibromatosis type 1: importance of genetic counseling.
    Terzi YK; Oguzkan-Balci S; Anlar B; Aysun S; Guran S; Ayter S
    Genet Couns; 2009; 20(2):195-202. PubMed ID: 19650418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of café au lait macules at initial consultation in the diagnosis of neurofibromatosis type 1.
    Nunley KS; Gao F; Albers AC; Bayliss SJ; Gutmann DH
    Arch Dermatol; 2009 Aug; 145(8):883-7. PubMed ID: 19687418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [From gene to disease; neurofibromatosis type 1].
    de Goede-Bolder A; Cnossen MH; Dooijes D; van den Ouweland AM; Niermeijer MF
    Ned Tijdschr Geneeskd; 2001 Sep; 145(36):1736-8. PubMed ID: 11572174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neurofibromatosis type 1 in childhood].
    Kongshaug N; Meyer B; Kolmannskog S
    Tidsskr Nor Laegeforen; 1999 Aug; 119(18):2653-7. PubMed ID: 10479978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Learning disabilities in children with neurofibromatosis type 1: subtypes, cognitive profile, and attention-deficit-hyperactivity disorder.
    Hyman SL; Arthur Shores E; North KN
    Dev Med Child Neurol; 2006 Dec; 48(12):973-7. PubMed ID: 17109785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical study of type 1 neurofibromatosis in north west England.
    McGaughran JM; Harris DI; Donnai D; Teare D; MacLeod R; Westerbeek R; Kingston H; Super M; Harris R; Evans DG
    J Med Genet; 1999 Mar; 36(3):197-203. PubMed ID: 10204844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eye disorders in neurofibromatosis (NF1).
    Kordić R; Sabol Z; Cerovski B; Katusić D; Jukić T
    Coll Antropol; 2005; 29 Suppl 1():29-31. PubMed ID: 16193672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unusual clustering of brain tumours in a family with NF1 and variable expression of cutaneous features.
    Faravelli F; Upadhyaya M; Osborn M; Huson SM; Hayward R; Winter R
    J Med Genet; 1999 Dec; 36(12):893-6. PubMed ID: 10593996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic outcome in children with multiple café au lait spots.
    Korf BR
    Pediatrics; 1992 Dec; 90(6):924-7. PubMed ID: 1344978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of intrafamilial phenotypic variation in neurofibromatosis 1 (NF1).
    Szudek J; Joe H; Friedman JM
    Genet Epidemiol; 2002 Aug; 23(2):150-64. PubMed ID: 12214308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of neurofibromatosis 1 upon quality of life in childhood: a cross-sectional study of 79 cases.
    Wolkenstein P; Rodriguez D; Ferkal S; Gravier H; Buret V; Algans N; Simeoni MC; Bastuji-Garin S
    Br J Dermatol; 2009 Apr; 160(4):844-8. PubMed ID: 19067713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neurofibromatosis type 1 complications in the pediatric age: follow-up of a hundred cases].
    Bonnemaison E; Roze-Abert B; Lorette G; Sirinelli D; Boscq M; Mazjoub S; De Courtivron B; Bonnard C; Despert F; Toutain A; Maheut-Lourmière J; Barthez MA; Castelnau P;
    Arch Pediatr; 2006 Jul; 13(7):1009-14. PubMed ID: 16716577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.